WINTON GROUP Ltd Reduces Position in Astera Labs, Inc. $ALAB

WINTON GROUP Ltd decreased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 33.2% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 5,252 shares of the company’s stock after selling 2,608 shares during the quarter. WINTON GROUP Ltd’s holdings in Astera Labs were worth $2,537,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC boosted its holdings in shares of Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after acquiring an additional 52 shares during the period. IFP Advisors Inc increased its holdings in shares of Astera Labs by 9.2% in the 2nd quarter. IFP Advisors Inc now owns 4,241 shares of the company’s stock valued at $2,048,000 after acquiring an additional 356 shares during the period. Baird Financial Group Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at $253,000. Arizona State Retirement System raised its position in Astera Labs by 8.1% in the 2nd quarter. Arizona State Retirement System now owns 39,042 shares of the company’s stock valued at $18,858,000 after purchasing an additional 2,909 shares during the last quarter. Finally, Nykredit A S acquired a new stake in Astera Labs during the 2nd quarter worth $19,990,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on ALAB shares. UBS Group reissued a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Susquehanna increased their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Finally, Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Trading Up 2.4%

Shares of ALAB stock opened at $291.22 on Friday. The stock has a 50 day simple moving average of $316.60 and a 200-day simple moving average of $260.17. The company has a market cap of $50.52 billion, a price-to-earnings ratio of 144.17 and a beta of 3.77. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the business earned $0.44 earnings per share. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 592,244 shares of company stock worth $209,729,973. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.